Schizophrenia trials in Bulgaria

In Bulgaria 15 Also abroad 473

15 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Evenamide in patients with treatment-resistant schizophrenia not responding to antipsychotics
Where
Burgas, Kazanlak, Plovdiv, Sofia, Varna, Veliko Tarnovo
Age
18 years and over
People
135 worldwide
Run by
Newron Pharmaceuticals S.p.A.
See details and how to join2024-519836-18-00 · EU 2024-519836-18-00
Phase 2Taking people
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
Where
Blagoevgrad, Cherven Bryag, Sofia, Stara Zagora, Vratsa
Age
55 years and over
People
370 worldwide
Run by
Intra-Cellular Therapies, Inc.
See details and how to joinNCT06540833
Phase 3Taking people
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
Where
Novi Iskir
Age
18 years to 65 years
People
472 worldwide
Run by
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT07686263 · EU 2025-523664-20-00
Phase 3Taking people
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Where
Plovdiv, Ruse, Sofia, Sofiya
Age
55 years to 90 years
People
406 worldwide
Run by
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT06585787 · EU 2024-516363-92-00
Phase 2Taking people
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
Where
Pernik, Ruse, Sofiya
Age
55 years to 90 years
People
300 worldwide
Run by
MapLight Therapeutics
See details and how to joinNCT06887192 · EU 2024-519820-26-00
Phase 3Taking people
NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Where
Lovech, Pleven, Plovdiv, Sliven, Vratsa
Age
18 years to 65 years
People
284 worldwide
Run by
Neurocrine Biosciences
See details and how to joinNCT07105098 · EU 2025-521215-39-00
Phase 3Taking people
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
Where
Lovech, Pleven, Plovdiv, Sliven, Vratsa
Age
18 years to 65 years
People
600 worldwide
Run by
Neurocrine Biosciences
See details and how to joinNCT07114874 · EU 2025-521216-19-00
Phase 2Taking people
A Clinical trial to evaluate the efficacy of vafidemstat in negative symptoms and cognitive impairment associated with schizophrenia. (EVOLUTION study)
Where
Kazanlik, Lovech, Novi Iskir, Pazardzhik, Pleven, Razgrad, Ruse, Sliven, Sofia, Sofiya, Varna
Age
18 years to 64 years
People
239 worldwide
Run by
Oryzon Genomics S.A.
See details and how to join2023-507372-42-00 · EU 2023-507372-42-00
Phase 3Taking people
Randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety of Roluperidone in adults with negative symptoms of schizophrenia
Where
Lovech, Novi Iskir, Sofia, Vratsa
Age
18 years to 64 years
People
120 worldwide
Run by
Minerva Neurosciences Inc.
See details and how to join2026-525925-19-00 · EU 2026-525925-19-00
Phase 2Enrolling by invitation
An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis
Where
Pernik, Sofiya
Age
55 years to 91 years
People
210 worldwide
Run by
MapLight Therapeutics
See details and how to joinNCT07459660 · EU 2025-521757-16-00
Phase 2Taking people
Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
Where
Haskovo, Kazanlak, Lovech, Plovdiv, Sliven, Sofia, Veliko Tarnovo, Vratsa
Age
18 years to 65 years
People
142 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07467993
Phase 2Taking people
Evaluation of NBI-1117570 in Inpatient Adults With Schizophrenia
Where
Kazanlik, Pazardzhik, Pleven, Targovishte
Age
18 years to 55 years
People
120 worldwide
Run by
Neurocrine Biosciences
See details and how to joinNCT07288333 · EU 2025-521868-35-00
Phase 2Taking people
A Phase 2 Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults with Schizophrenia (STAR-1)
Where
Burgas, Haskovo, Kazanlik, Lovech, Plovdiv, Sliven, Sofia, Veliko Tirnovo, Vratsa
Age
18 years to 64 years
People
42
Run by
Novartis Pharma AG
See details and how to join2025-524058-32-00 · EU 2025-524058-32-00
Phase 3Taking people
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
Where
Sofia, Targovishte
Age
13 years to 17 years
People
330 worldwide
Run by
Gedeon Richter Plc.
See details and how to joinNCT03817502 · EU 2024-513194-44-00
Phase 1Not yet taking people in Bulgaria
A Randomized, Multiple-Dose, Open-Label, Parallel-Group Study to Evaluate the Pharmacokinetic Profiles of LY03010 and the Relative Bioavailability at Steady-State of LY03010 versus XEPLION® in Patients with Schizophrenia
Where
Kazanlak, Pazardzhik, Pleven, Sliven, Sofia, Targovishte, Tsarev Brod, Varna, Veliko Tirnovo, Vratsa
Age
18 years and over
People
170 worldwide
Run by
Geneora Pharma (Shijiazhuang) Co. Ltd.
See details and how to join2023-508981-13-00 · EU 2023-508981-13-00